Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis

NCT: NCT06485505 · RECRUITING

NCT IDNCT06485505
StatusRECRUITING
Start Date2024-07-12
Completion2026-12

Brief Summary

3 groups of patients with onychomycosis will be recruited. Group A will receive itraconazole alone. Group B will receive itraconazole + low dose isotretinoin and group C will be treated with itraconazole + excimer light sessions.

Frequently Asked Questions

What is Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis?

Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis is a clinical trial registered under NCT06485505. Current status: RECRUITING.

What is the status of NCT06485505?

The current status of NCT06485505 (Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis) is: RECRUITING.

When did Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis start?

Isotretinoin Versus Excimer Light an Adjuvant in Treating Onychomycosis started on 2024-07-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑